Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: The utility of immunocytochemical panel
β Scribed by Husain A. Saleh; Michael Aulicino; Sayed Y. Zaidi; Aurang Zeb Khan; Shahla Masood
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 484 KB
- Volume
- 37
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.20982
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Diagnosing liver tumors by fine-needle aspiration biopsy is safe and accurate. However, there are cases that prove diagnostically difficult. Traditionally, immunostains for β£-fetoprotein and polyclonal carcinoembryonic antigen have been used to distinguish adenocarcinomas from hepat
## Background: Difficulties with cytologic diagnoses on fine-needle aspiration cytology (fnac) of the liver can be overcome by the application of immunocytochemical panels applied on smears. the aim of the current study was to analyze the performance of a panel of monoclonal antibodies to different
Fine-needle aspiration (FNA) cytology is a useful tool for diagnosis of primary malignancies and metastatic lesions of the liver. However, well-differentiated hepatocellular carcinoma (HCC) may resemble benign/reactive hepatocytes, and less differentiated HCC may simulate poorly differentiated adeno